Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

People who inject drugs

Active injecting drug users must be provided with adherence support when they start HIV therapy

News
20 June 2012
New & experimental HIV treatments

European Medicines Agency Validates Gilead ’s Marketing Application for Elvitegravir for Treatment of HIV Infection

Editor's pick
Gilead press release
19 June 2012
Bad science & bogus treatments

Sowetan villainizes life-saving treatment: Another “ARV boob” booby

Editor's pick
JournAIDS
18 June 2012
Undetectable viral load & treatment as prevention

Belt AND Suspenders?

Editor's pick
Positive Lite
18 June 2012
Undetectable viral load & treatment as prevention

Is treatment as prevention ready to roll out, or do we need to know more?

News
15 June 2012
New & experimental HIV treatments

New Drug-Screening Method Yields Long-Sought Anti-HIV Compounds

Editor's pick
Scripps Research Institute
15 June 2012
How HIV works

Immediate Antiretroviral Therapy Reduces HIV Infection of Resting CD4 T-Cells

Editor's pick
HIVandHepatitis.com
14 June 2012
Undetectable viral load & treatment as prevention

Study shows that use of darunavir/ritonavir and etravirine in HIV treatment as a prevention method is biologically plausible

News
13 June 2012
Adherence

HIV-Positive Drinkers Choose Alcohol Over ART

Editor's pick
Medscape (requires free registration)
12 June 2012
Side effects

South Africa: Stavudine Trial Causes Split

Editor's pick
AllAfrica
11 June 2012
Undetectable viral load & treatment as prevention

World Health Organization sets out route map for scale-up of treatment as prevention

News
11 June 2012
Access to healthcare

South Africa: Addressing Tenofovir Shortages

Editor's pick
AllAfrica
8 June 2012
Resistance

Researchers find that pre-existing mutations can lead to drug resistance in HIV virus

Editor's pick
Medical Xpress
8 June 2012
Changing treatment

Big delays in switching to second-line ART in South Africa

News
8 June 2012
Undetectable viral load & treatment as prevention

New report: evaluating HIV treatment as prevention in the European context

Editor's pick
European Centre for Disease Prevention and Control (ECDC) press release
7 June 2012
New & experimental HIV treatments

UBC drug formulation receives $1.1 million for clinical development as HIV treatment

Editor's pick
EurekAlert (press release)
6 June 2012
Access to healthcare

Deadly Chagas affects millions and needs attention, but calling it new HIV is a publicity stunt

Editor's pick
U.S. News & World Report
2 June 2012
Health services & systems

Are we wasting money on care that patients don’t want?

Editor's pick
The King's Fund
1 June 2012
Side effects

European Medicines Agency boosts EU transparency with online publication of suspected side effect reports

Editor's pick
European Medicines Agency press release
1 June 2012
Undetectable viral load & treatment as prevention

The ethical implications of “treatment as prevention” in the United States

Editor's pick
HIV/AIDS Policy & Law Review
31 May 2012
Access to healthcare

South Africa: Tenofovir Shortages Continue

Editor's pick
AllAfrica
31 May 2012
HIV treatment

FDA turns down higher dosage for HIV drug Prezista

Editor's pick
Med City News
30 May 2012
PrEP

Adherence Challenges in Intermittent HIV PrEP Study

Editor's pick
AIDSMeds
30 May 2012
PrEP

Study Reports Data on the Use of Intermittent ARV-Based Pre-Exposure Prophylaxis for HIV Prevention

Editor's pick
IAVI press release
28 May 2012